2012, Number 603
<< Back Next >>
Rev Med Cos Cen 2012; 69 (603)
Melanoma, análisis estadístico, servicio de Cirugía Plástica, reconstructiva y estética en el Hospital México durante Enero 1999 hasta Diciembre del 2009
Badilla MJ
Language: Spanish
References: 15
Page: 401-408
PDF size: 199.58 Kb.
ABSTRACT
In recent years, has progressively increased the interest on malignant melanoma, a type of skin cancer very aggressive and potentially fatal. Epidemiological data concerning this tumor are alarming because its incidence is increasing in many countries, at an approximate rate of 5% per year. Currently, melanoma is the leading cause of death from skin cancer, accounting for 65-75% of them, and 1-2% of all cancer deaths. In Australia, malignant melanoma (MM) is one of the most common cancers. Recent studies have led to correlate multiple factors that predict the likelihood of developing the disease, in patients already affected, the occurrence of metastatic disease and death. They have allowed the development of new systems of staging and treatment. Early detection of these tumors is vital to reduce mortality and may be achieved by simple inspection or examinations, as the gross appearance of the primary cutaneous tumor usually feature, allowing the diagnosis about 90% of them.
REFERENCES
American Cancer Society. Cancer facts and figures. New York: American Cancer Society, Inc.; 2002.
Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3:395–401.
Ascierto PA, Satriano RA, Palmiere G, et al. Epiluminescence microscopy as a useful approach in the early diagnosis of cutaneous malignant melanoma. Melanoma Res 1998; 8:529–37.
Bataille V, Bishop JA, Sasieni P, et al. Risks of cutaneous melanoma in relation to the numbers, types, and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605–11.
Berking C, Takemoto R, Satyamoorthy K, et al. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 2001; 158:943–53.
Burton RC. Malignant melanoma in the year 2000. CA Cancer J Clin 2000; 50:209–13.
Castilla EE, de Graca M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi. Naevi: I. Incidence rates and relative frequencies. Br J Dermatol 1981; 104:307–15.
Ceballos PI, Ruiz-Maldonado R, Mihm MC. Melanoma in children. N Engl J Med 1995; 332:656–62.
Chuang TY, Charles J, Reizner GT, et al. melanoma in Kauai, Hawaii, 1981–1900: the significance of in situ melanoma and the incidence trend. Int J Dermatol 1999; 38: 101–7.
Clark WH Jr, Elder DE, Guery D, IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893–904.
deRooij MJ, Rampen FH, Schouten LF, et al. Skin cancer screening focusing on melanoma yields more selective attendance. Arch Dermatol 1995; 131: 422–5.
English DR, Armstrong BK, Kricker A, et al. Sunlight and cancer. Cancer Causes Control 1997; 8: 271–83.
Swetter SM. Malignant melanoma.eMedicine Journal [serial online] 2002. Available at: http://www.emedicine.com/derm/topic257.htm.
Full text